Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
First HAYAT Annual Patients Forum 21st March 2010 Al Hashimi II Ballroom – SAS Hotel Kuwait First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait Access to medicine is essential for better outcome Dr. Jaroslav Nemec Consultant Medical Oncologist Head of GI Unit, Medical Oncology Department - KCCC First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait Cancer Therapy • Many cancer patients require surgery and radiotherapy and medical therapy • All medicines we use have been scientifically proven to be effective and beneficial First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait Cancer Therapy • All anticancerous medicines are expensive • Prices ranging from dozens to thousands KD monthly • Some patients may require medicines for years First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait Cancer Therapy • Medicines may cure some cancers, or extend the life of incurable patients • Access to medicines is critical for cure or extending the lives First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait Cancer Therapy • Almost all cancer medicines in Kuwait are granted for all patients • Only few expensive medicines may not be provided for non-Kuwaiti patients • HERE THE HAYAT FUND COMES First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait SHARING DOCTOR’S THOUGHTS HOW TO USE THE HAYAT SUPPORT FOR THE BEST BENEFIT OF OUR PATIENTS First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait SHARING DOCTOR’S THOUGHTS • All medicines we use have been rigorously tested to be proven beneficial • More expensive not always means more beneficial • Some expensive medicines save lives, some add little First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait MEDICAL ONCOLOGY DEPARTMENT POLICY • Selecting the patients who would benefit most • Selecting the medicines wisely = those providing most of the benefit First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait MEDICAL ONCOLOGY DEPARTMENT POLICY HAYAT Supports several expensive drugs used at the Medical Oncology Department for different cancers First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait BREAST CANCER • Class: Molecular targeted agents • Used for a specific type of breast cancer, specially tested for benefit from the drugs • Injections and tablets • Cost: 1000-1500 KD monthly. Many patients would be on treatment for more than a year, even few years. First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait BREAST CANCER • Benefit from the drugs: • After operation, the risk of cancer returning is reduced • In advanced breast cancer, these drugs improve benefit from chemotherapy and hormonal therapy (more patients would experience tumor shrinkage and live longer) and reduces symptoms induced by the disease First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait BREAST CANCER • Class: Hormonal therapy • Used for a specific type of breast cancer, specially tested for benefit from the drugs • Tablets • Cost: 95 KD/month, 1140 KD/year. Many patients would be on treatment for more than a year, even few years. First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait BREAST CANCER • Benefit from the drug: • After operation, the risk of cancer returning is reduced • In advanced breast cancer, the drug prolongs the life and reduces symptoms induced by the disease First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait NON-HODGKIN’S LYMPHOMA • Class: monoclonal antibody • Used in some specific types of non-Hodgkin’s lymphoma, in combination with chemotherapy or alone • Cost: One dose = about 800 KD, total cost varies according to the schedule, may exceed 7,000 KD First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait NON-HODGKIN’S LYMPHOMA • Benefit from the drug: • More patients would be cured with chemotherapy • In patients who can’t be cured, the drug prolongs the life and reduces symptoms induced by the disease First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait MEDICINES SUPPORTED BY HAYAT FUND USED IN DIFFERENT CANCERS 1) The drug controlling vessels supplying the tumor with blood • Effective in colon, lung, ovarian, breast, brain cancers. • Cost: May differ in different cancers. Around 1300 KD/months, 4000 KD/3 months • Benefit: Improves benefit from chemotherapy, prolongs life in some cancers, reduces problems from disease First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait MEDICINES SUPPORTED BY HAYAT FUND USED IN DIFFERENT CANCERS 2) The drugs used in lung, pancreatic, liver, kidney cancers and rare diseases of digestive tract: • Different classes of drugs • Don’t cure the disease • May prolong life, prolong time the tumor is not growing, control symptoms of cancer • Cost: Very different. 1000 – 2000 KD/month, used for several months, some for several years. First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait SUPPORT FROM HAYAT FUND IS CRITICAL FOR MANY OF OUR PATIENTS USING THE SUPPORT WISELY AND EFFECTIVELY IS DOCTORS’ CONTRIBUTION First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait Thank You Dr. Jaroslav Nemec Consultant Medical Oncologist Head of GI Unit, Medical Oncology Department - KCCC First HAYAT Annual Patients Forum – 21st March 2010 – SAS, Kuwait